Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 13NIH 6INDUSTRY 5OTHER_GOV 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Head & Neck 2Other neoplasm 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 3216Carcinoma, Non-Small-Cell Lung 2729Breast Neoplasms 2551Colorectal Neoplasms 1463Prostatic Neoplasms 1307Neoplasm Metastasis 1301Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 945Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

Endoscopy 2Eicosapentaenoic Acid 2Restraint, Physical 1Colonoscopy 1Clinical Chemistry Tests 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Hyperplasia × Clear all
NCT04622462 2024-11-07

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Proteocyte Diagnostics Inc.

Recruiting
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Neoplasms, Keratoderma, Palmoplantar, Epidermolytic

NCT05853783 2024-11-07

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTEâ„¢

Proteocyte Diagnostics Inc.

Recruiting
180 enrolled
Head & Neck

Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Diseases, Keratoderma, Palmoplantar, Epidermolytic

NCT02121873 2023-07-20

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

Atossa Therapeutics, Inc.

Completed
6 enrolled
BreastOther neoplasm

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hyperplasia, Precancerous Conditions

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡